NCT00995098

Brief Summary

There is increasing evidence that indicates early enteral nutrition may be associated with improved outcome in acute pancreatitis patients. However, most of the clinical trials regarding this targeted mild to moderated pancreatitis patients. In regard to severe acute pancreatitis (SAP) patients, current results from randomized control trials (RCTs) are inconclusive. The researchers of this study aim to investigate the impact of early enteral nutrition on the clinical outcomes of SAP patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2009

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 15, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
Last Updated

November 30, 2010

Status Verified

November 1, 2010

Enrollment Period

9 months

First QC Date

October 11, 2009

Last Update Submit

November 29, 2010

Conditions

Keywords

Acute severe pancreatitisnutritional supportenteral nutritionparenteral nutrition

Outcome Measures

Primary Outcomes (1)

  • All cause mortality

    Three months

Secondary Outcomes (4)

  • Pancreatic sepsis

    Three months

  • Length of hospitalization

    From admission to discharge

  • Operation ratio

    From admission to discharge

  • Cost of hospitalization

    From admission to discharge

Study Arms (2)

Early enteral nutrition

EXPERIMENTAL

Twenty patient will be enrolled into this arm. Enteral nutrition administration will start within 24 hours after admission through naso-jejunal tube and continue for 7 days after admission.Naso-jejunal tube will be set up by endoscopy.

Dietary Supplement: early enteral nutrition

Control: Parenteral Nutrition

ACTIVE COMPARATOR

Twenty patient will be enrolled into this arm. PN administration will start within 24 hours after admission and continue for 7 days after admission.Parenteral nutrition will be administered through subclavian central venous catheter.

Dietary Supplement: Parenteral nutrition

Interventions

early enteral nutritionDIETARY_SUPPLEMENT

Enteral nutrition will be administered within 24 hours of admission through naso-jejunal tube and continue for 7 days after admission. Naso-jejunal tube will be set up by endoscopy. X-ray will be used to place the distal end of the feeding tube and EN would not start until the distal end of the feeding tube has been placed at the remote end of Treitz ligament. Standard enteral nutrition liquid regimen (Nutrison Fibre) will be used. Patients are targeted to receive calories for 25 kcal/kg/day and nitrogen for 0.2g/kg/day.

Also known as: Nutrison Fibre
Early enteral nutrition
Parenteral nutritionDIETARY_SUPPLEMENT

PN administration will start within 12 hours of admission and continue for 7 days after admission. Patients will receive calories for 25 kcal/kg and nitrogen for 0.2g/kg. Twenty percent of the calories will be provided by fat emulsion (LCT/MCT) and the remaining will be provided by dextrose. Nitrogen will be provided by balanced amino acids injection (Novamin). All PN components will be compounded into 3-liters bags under sterile conditions. Nutrition regimen will be administered through subclavian central venous catheter.

Also known as: Lipovenoes(LCT/MCT fat emulsion, 20%), Novamin (11.4%)
Control: Parenteral Nutrition

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of severe acute pancreatitis
  • Consent informed

You may not qualify if:

  • Diabetes mellitus
  • Allergy for any ingredient of PN or EN regimen
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

Chengdu, Sichuan, 610072, China

Location

Related Publications (3)

  • Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ. 2004 Jun 12;328(7453):1407. doi: 10.1136/bmj.38118.593900.55. Epub 2004 Jun 2.

    PMID: 15175229BACKGROUND
  • Meier R, Beglinger C, Layer P, Gullo L, Keim V, Laugier R, Friess H, Schweitzer M, Macfie J; ESPEN Consensus Group. ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr. 2002 Apr;21(2):173-83. doi: 10.1054/clnu.2002.0543. No abstract available.

    PMID: 12056792BACKGROUND
  • McClave SA, Chang WK, Dhaliwal R, Heyland DK. Nutrition support in acute pancreatitis: a systematic review of the literature. JPEN J Parenter Enteral Nutr. 2006 Mar-Apr;30(2):143-56. doi: 10.1177/0148607106030002143.

    PMID: 16517959BACKGROUND

MeSH Terms

Conditions

Pancreatitis, Acute NecrotizingHyperphagia

Interventions

Parenteral NutritionNovaMin

Condition Hierarchy (Ancestors)

PancreatitisPancreatic DiseasesDigestive System DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Bin Cai, M.D

    Sichuan Academy of Medical Sciences

    STUDY DIRECTOR
  • Hua Jiang, M.D

    Sichuan Academy of Medical Sciences

    PRINCIPAL INVESTIGATOR
  • Jun Zeng, M.D

    Sichuan Academy of Medical Sciences

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 11, 2009

First Posted

October 15, 2009

Study Start

October 1, 2009

Primary Completion

July 1, 2010

Study Completion

October 1, 2010

Last Updated

November 30, 2010

Record last verified: 2010-11

Locations